HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukio Kobayashi Selected Research

monosomy 6q Chromosome 6

1/2018Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukio Kobayashi Research Topics

Disease

23Lymphoma (Lymphomas)
01/2019 - 01/2002
18Neoplasms (Cancer)
06/2021 - 01/2002
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 08/2002
11Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2021 - 05/2007
11B-Cell Lymphoma (Lymphoma, B Cell)
02/2021 - 01/2002
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 02/2006
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2018 - 06/2009
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2022 - 09/2010
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 06/2009
7Leukemia
12/2020 - 08/2002
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018 - 01/2009
6Philadelphia Chromosome
01/2022 - 06/2009
6Hematologic Neoplasms (Hematological Malignancy)
08/2017 - 08/2002
5T-Cell Lymphoma (Lymphoma, T Cell)
10/2015 - 12/2002
4Acute Promyelocytic Leukemia
12/2020 - 04/2013
4Disease Progression
12/2020 - 08/2016
4Thrombocytopenia (Thrombopenia)
10/2018 - 08/2010
4Hodgkin Disease (Hodgkin's Disease)
05/2018 - 01/2013
4Infections
08/2016 - 03/2002
4Neutropenia
07/2015 - 08/2010
3Febrile Neutropenia
11/2021 - 12/2010
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2021 - 01/2009
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
07/2019 - 11/2003
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2017 - 01/2013
3Pneumonia (Pneumonitis)
04/2017 - 10/2010
3Multiple Myeloma
10/2015 - 01/2008
3Leukopenia
07/2015 - 08/2010
2Residual Neoplasm
01/2022 - 01/2018
2Anemia
11/2021 - 12/2010
2Hemorrhage
12/2020 - 10/2004
2Diarrhea
08/2017 - 10/2004
2Fever (Fevers)
04/2017 - 11/2008
2Abdominal Pain (Pain, Abdominal)
08/2016 - 05/2007
2Lymphopenia (Lymphocytopenia)
07/2015 - 08/2010
2Plasmacytoma
01/2015 - 02/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2013 - 05/2004
2Burkitt Lymphoma (Burkitt's Lymphoma)
12/2010 - 05/2004
2Anorexia
08/2010 - 01/2010
1Leukocytosis (Pleocytosis)
12/2020
1Bites and Stings (Sting)
04/2020
1Paraproteinemias (Monoclonal Gammopathy)
07/2019
1Tumor Lysis Syndrome
10/2018
1Syncope (Fainting)
10/2018

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
02/2021 - 11/2008
7Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 06/2009
6Prednisolone (Predate)FDA LinkGeneric
01/2022 - 11/2008
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 11/2008
6Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 11/2008
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 11/2008
4nilotinibFDA Link
01/2017 - 06/2009
3Azacitidine (5 Azacytidine)FDA Link
11/2022 - 09/2011
3Dasatinib (BMS 354825)FDA Link
01/2022 - 06/2011
3Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2020 - 11/2014
3Pharmaceutical PreparationsIBA
10/2018 - 08/2010
3AntibodiesIBA
05/2018 - 06/2009
3Proteins (Proteins, Gene)FDA Link
02/2018 - 02/2005
3Histone Deacetylase InhibitorsIBA
01/2018 - 01/2010
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2004
3Monoclonal AntibodiesIBA
10/2017 - 06/2009
3Tyrosine Kinase InhibitorsIBA
09/2017 - 04/2012
3SteroidsIBA
08/2016 - 03/2002
3Methotrexate (Mexate)FDA LinkGeneric
10/2015 - 12/2010
2EnzymesIBA
11/2022 - 10/2012
2blinatumomabIBA
06/2022 - 04/2020
2gilteritinibIBA
11/2021 - 10/2018
2Cyclin D1IBA
06/2021 - 01/2002
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020 - 10/2018
2Anti-Bacterial Agents (Antibiotics)IBA
07/2019 - 08/2010
2Immunoglobulin M (IgM)IBA
07/2019 - 01/2015
2mogamulizumabIBA
01/2019 - 10/2017
2tamibaroteneIBA
01/2019 - 11/2014
2bosutinibIBA
09/2017 - 01/2015
2Vasopressins (Vasopressin)IBA
08/2016 - 05/2007
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2015 - 01/2002
2Epstein-Barr virus encoded RNA 1IBA
01/2015 - 01/2013
2Gemtuzumab (Mylotarg)FDA Link
07/2011 - 05/2009
2Etoposide (VP 16)FDA LinkGeneric
12/2010 - 11/2009
2CalicheamicinsIBA
08/2010 - 05/2009
2Bortezomib (Velcade)FDA Link
11/2008 - 01/2008
2CladribineFDA LinkGeneric
10/2004 - 07/2004
1pevonedistatIBA
11/2022
1ibrutinibIBA
06/2021
1AnticoagulantsIBA
12/2020
1Hemoglobins (Hemoglobin)IBA
12/2020
1AmylasesFDA Link
10/2018
1fms-Like Tyrosine Kinase 3IBA
10/2018
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2018
1AnthracyclinesIBA
06/2018
1LigandsIBA
05/2018

Therapy/Procedure

31Therapeutics
06/2022 - 03/2002
19Drug Therapy (Chemotherapy)
01/2022 - 12/2002
5Chemoradiotherapy
06/2018 - 02/2006
5Transplantation
01/2018 - 07/2002
4Hematopoietic Stem Cell Transplantation
01/2022 - 09/2010
4Stem Cell Transplantation
01/2019 - 05/2004
3Radiotherapy
02/2021 - 02/2006
3Combination Drug Therapy (Combination Chemotherapy)
04/2016 - 02/2006
2Cell Transplantation
01/2018 - 04/2013
1Oral Administration
06/2021
1Remission Induction
12/2020